Nasdaq Prta News Today

Shares of Prothena Co. plc (NASDAQ:PRTA – Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as $21.91 and last traded at $22.18, with a volume of 40918 shares trading hands. The stock had previously closed at $23.54. Analyst Ratings Changes Several research firms have commented […]

Shares of Prothena Co. plc (NASDAQ:PRTA – Get Free Report) have been given an average rating of “Moderate Buy” by the nine brokerages that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year […]

Prothena Co. plc (NASDAQ:PRTA – Free Report) – Analysts at Cantor Fitzgerald issued their FY2024 EPS estimates for Prothena in a research note issued to investors on Monday, February 19th. Cantor Fitzgerald analyst C. Duncan anticipates that the biotechnology company will earn ($4.61) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating […]

Silverarc Capital Management LLC cut its stake in Prothena Co. plc (NASDAQ:PRTA – Free Report) by 46.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 26,629 shares of the biotechnology company’s stock after selling 23,092 shares during the period. Silverarc Capital Management […]

Silverarc Capital Management LLC decreased its stake in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) by 46.4% in the 3rd quarter, Holdings Channel reports. The fund owned 26,629 shares of the biotechnology company’s stock after selling 23,092 shares during the quarter. Silverarc Capital Management LLC’s holdings in Prothena were worth $1,285,000 as of […]

Prothena Co. plc (NASDAQ:PRTA – Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 5,750,000 shares, a decrease of 8.1% from the January 15th total of 6,260,000 shares. Based on an average daily trading volume, of 845,900 […]

Prothena Co. plc (NASDAQ:PRTA – Get Free Report) was the recipient of a large decline in short interest in January. As of January 31st, there was short interest totalling 5,750,000 shares, a decline of 8.1% from the January 15th total of 6,260,000 shares. Based on an average trading volume of 845,900 shares, the short-interest ratio […]

Prothena Co. plc (NASDAQ:PRTA – Get Free Report) saw a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 5,750,000 shares, a decrease of 8.1% from the January 15th total of 6,260,000 shares. Based on an average daily trading volume, of 845,900 shares, the short-interest […]

Headlands Technologies LLC bought a new position in Prothena Co. plc (NASDAQ:PRTA – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,531 shares of the biotechnology company’s stock, valued at approximately $74,000. Other large investors have also made changes to their positions […]

Headlands Technologies LLC purchased a new position in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 1,531 shares of the biotechnology company’s stock, valued at approximately $74,000. Several other hedge funds have also recently […]